# Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

> **NCT02089100** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 154 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** stereotactic body radiation therapy
- **RADIATION:** Systemic treatment

## Key facts

- **NCT ID:** NCT02089100
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-02-26
- **Primary completion:** 2033-10
- **Final completion:** 2034-10
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02089100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02089100, "Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02089100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
